Blunting of AICAR-induced human skeletal muscle glucose uptake in type 2 diabetes is dependent on age rather than diabetic status.
about
Energy disruptors: rising stars in anticancer therapy?Epinephrine and AICAR-induced PGC-1α mRNA expression is intact in skeletal muscle from rats fed a high-fat dietType 2 diabetes is associated with altered NF-κB DNA binding activity, JNK phosphorylation, and AMPK phosphorylation in skeletal muscle after LPS.Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase.Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.A marriage of two "Methusalem" drugs for the treatment of psoriasis?: Arguments for a pilot trial with metformin as add-on for methotrexate.Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations.AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseasesThe therapeutic potential of GPR43: a novel role in modulating metabolic health.5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl 5'-Monophosphate (AICAR), a Highly Conserved Purine Intermediate with Multiple Effects.Role of AMP-Activated Protein Kinase for Regulating Post-exercise Insulin Sensitivity.Monitoring metabolites consumption and secretion in cultured cells using ultra-performance liquid chromatography quadrupole-time of flight mass spectrometry (UPLC-Q-ToF-MS).Intra-arterial AICA-riboside administration induces NO-dependent vasodilation in vivo in human skeletal muscle.AMPK in skeletal muscle function and metabolism.A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators.
P2860
Q26771300-3CF597DB-7690-42AE-BEEB-54E29CD18E63Q28567454-828AAC4E-DBEF-499A-A498-1DD53B7C265CQ34023225-4B49D74A-BC31-472D-9714-9CE40F091AACQ34611635-3C837E93-A43B-4590-9731-838C16829AAEQ36402509-E2352338-0435-49CE-A1F7-54C3046BDDFCQ37170305-E4908270-5F9F-496E-97C0-BC32EDDF38BFQ37531997-70C9963B-6F94-4F0B-A7E0-A7155C9CFD65Q38026549-AE3E3F6B-5EE4-49CF-9F97-82A3B3FD0FBDQ38121495-E6AA1F38-0E88-4D2A-AC34-4C2F694E4C78Q38222605-D6F6AF08-732D-41C5-A445-10D61A548CA2Q38998401-710C4FF7-E83C-4CFD-8D1F-DE9D38E7C2C3Q39430006-3A114871-361E-4088-981E-ADC72B169F5DQ45929265-CE5E2CFD-DECB-4802-8AE7-6AD0D36E7667Q47781006-46F240A6-9B1C-4FF6-AD60-B3CDCC397DFDQ54365047-53BBD819-9D37-4A65-AF6F-F09C778EAA23
P2860
Blunting of AICAR-induced human skeletal muscle glucose uptake in type 2 diabetes is dependent on age rather than diabetic status.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Blunting of AICAR-induced huma ...... e rather than diabetic status.
@en
Blunting of AICAR-induced huma ...... e rather than diabetic status.
@nl
type
label
Blunting of AICAR-induced huma ...... e rather than diabetic status.
@en
Blunting of AICAR-induced huma ...... e rather than diabetic status.
@nl
prefLabel
Blunting of AICAR-induced huma ...... e rather than diabetic status.
@en
Blunting of AICAR-induced huma ...... e rather than diabetic status.
@nl
P2093
P2860
P50
P921
P1476
Blunting of AICAR-induced huma ...... e rather than diabetic status.
@en
P2093
Graham Leese
John Andree Babraj
Kenneth Smith
Kevin Green
Kristy Mustard
Mhari C Towler
Michael J Rennie
Shaui Chen
P2860
P304
P356
10.1152/AJPENDO.90811.2008
P577
2009-02-03T00:00:00Z